Growth Stock Outlook 2026: AI, Biotech, and Infrastructure Lead H1 Picks
As market volatility persists in early 2026, analysts are pivoting toward high-conviction growth plays in healthcare AI and specialized compute infrastructure. Key picks include Eli Lilly's pharmaceutical dominance and Nebius's explosive ARR projections, signaling a shift toward companies with proven revenue scaling.